© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Dogecoin is the new GameStop – Are investors going to get burned?
Finance
21/04/2021Dogecoin is the new GameStop – Are investors going to get burned?

Dogecoin has become the new GameStop, with frenzied trading potentially going to deliver a bloody nose to novice investors, warns the CEO of one of the world’s largest independent financial advisory and fintech organisations.

Read Full PostRead - Eye Icon
Journey To The Future
Innovation
07/12/2022Journey To The Future

The customer journey is one which can have a transformative effect on a business’s success, with new technologies opening the door to exciting opportunities.

Read Full PostRead - Eye Icon
Insurance Company Approached You To Settle A Claim: Here’s What To Do
News
07/03/2022Insurance Company Approached You To Settle A Claim: Here’s What To Do

If you have been injured in an accident, you are probably in a lot of pain. You may have to attend multiple doctor’s appointments and miss plenty of work. You just want this all to be over with and to get back to your normal life.  When an insurance

Read Full PostRead - Eye Icon
2016’s Alternative Investment Top Twenty-Five – Japan
Finance
01/11/20162016’s Alternative Investment Top Twenty-Five – Japan

First established in April 2005, Stats Investment Management Co., Ltd. is a hedge fund manager based in Japan specialising in managing Japanese equity long/short strategies.

Read Full PostRead - Eye Icon
Cities of Tomorrow: What Will the Future Look Like?
Innovation
06/05/2015Cities of Tomorrow: What Will the Future Look Like?

How to secure data privacy and make urban spaces more user-friendly for residents will be two of the top priorities that shape tomorrow's cities.

Read Full PostRead - Eye Icon
Meeting the Highest Standards of Competence and Professionalism
Leadership
30/08/2019Meeting the Highest Standards of Competence and Professionalism

Boccadutri is an Italian law firm that specialises in assisting international clients with legal matters in Italy and Italian clients abroad.

Read Full PostRead - Eye Icon
relayr Completes Second Strategic Acquisition
Innovation
28/02/2017relayr Completes Second Strategic Acquisition

relayr, the global enterprise Internet-of-Things (IoT) platform provider, announces its second strategic acquisition within two months.

Read Full PostRead - Eye Icon
A Most Effective Way to Finance Working Capital
Finance
13/02/2024A Most Effective Way to Finance Working Capital

With a portfolio of more than 15,000 happy customers relying on it to aid in the optimisation of their working capital and the reduction of risk to their supply chains, eFactor Network SAPI de CV boasts a state-of-the-art financing platform that improves overa

Read Full PostRead - Eye Icon
Accounting for SMEs
Leadership
01/10/2015Accounting for SMEs

It is vital for business owners and directors of small companies to ensure that they have accountants on board that they can trust and who can support them in running a successful business.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow